- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04869423
Animal-Assisted Therapy in Adolescents With Eating Disorders
Effects of Dog-assisted Therapy in Adolescents With Eating Disorders: a Controlled Trial.
This study aims to improve eating disorders symptomatology, mental, psychosocial and physical health, quality of life, strength and body composition of adolescents with eating disorders by the development of a dog-assisted therapy program.
The current research will involve thirty-two patients distributed equally in a control and an experimental group. The intervention group will participate once a week in a dog-assisted therapy of seven weeks. Moreover, all the included patients will participate in an assessment session before and after the intervention to compare the effects of the dog-assisted therapy within and between groups in anxiety, depression, character, behavior, eating disorder evolution, health-related quality of life, treatment satisfaction, strength and body composition.
Based on previous studies on different populations, it is expected that, compared to the control group, the experimental group may experience a potential reduction in anxiety, depression and symptoms, while improving quality of life, strength, body composition and behavior.
Study Overview
Status
Intervention / Treatment
Detailed Description
Animal-Assisted Therapies (AAT) have proved to increase self-esteem, social capacity and impulse control while reducing anxiety and depression. Thus, AAT could be an innovative and effective therapy to improve the mental, social and physical health of adolescents with eating disorders.
Based on previous studies on different populations, it is expected that, compared to the control group, the experimental group may experience a potential reduction in anxiety, depression and symptoms, while improving quality of life, strength, body composition and behavior.
Thirty-two adolescents, younger than 18 years and diagnosed with eating disorders from the University Hospital Niño Jesus will participate in this study. The informed consent must be signed to be included in the study.
The intervention will consist of 7 weeks conducted once a week (50 minutes each session). It will include three parts: 1) a welcome part aimed to get in touch with the dog, 2) a main part, where participants will be taught basic notions about dog training and then try to train the dogs. In this part, the patients will perform different activities and exercises with the dog. 3) A closing part to say goodbye to the dogs.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Madrid, Spain, 28009
- Niño Jesús University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adolescents in the Psychiatry and Psychology Service of the Niño Jesús University Hospital
- Patients diagnosed with eating disorders
- Adolescents with the willingness to participate and availability to assist
- Having read and signed the written informed consent.
Exclusion Criteria:
- Patients with dog-allergy or dog phobia
- Adolescents with a history of impulsive animal aggression
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Participants in this group will simply continue with their daily living and therapies.
Assessments will be conducted before and after the 7wk program but patients in this group will not take part in it
|
|
Experimental: Experimental group
Participants in this group will take part in 7 dog-assisted therapy sessions (1 per week).
This therapy will be added to their usual daily living and therapies.
Assessments will be conducted before and after the 7-week program.
|
During seven weeks patients will assist one time per week (1 hour).
The therapy will be conducted by an expert psychologist.
The intervention will consist of 7 weeks conducted once a week (50 minutes each session).
It will include three parts: 1) a welcome part aimed to get in touch with the dog, 2) a main part, where participants will be taught basic notions about dog training and then try to train the dogs.
In this part, the patients will perform different activities and exercises with the dog.
3) A closing part to say goodbye to the dogs.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Eating disorder symptoms
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by the EDI-2 questionnaire to evaluate the evolution of anorexia nervosa and bulimia nervosa normal symptoms.
The EDI 2 is a 91 item scale with 8 subscales - (Drive for thinness, Bulimia, body dissatisfaction, ineffectiveness, perfection, interpersonal distrust, interoceptive awareness and maturity fears.).
Respondents rate each item from 5 (usually), to 0 (never).
Higher scores mean more severe symptoms.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Changes in Health-related quality of life
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by the Kidscreen-10, which consists of 10 items scored on a 5-point Likert scale.
Scores range between 10 and 50, and a higher score means better health-related quality of life.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Anxiety
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by the STAI-C questionnaire.
It includes two different scales, one to asses state anxiety (20 items) and the other one to evaluate trait anxiety (20 items) in Spanish adolescents.
Each item is rated from 1 to 3 thus, scores in each sub-scales can range from a minimum of 20 to a maximum score of 60.
Higher scores mean higher anxiety.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Changes in Depression
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by the Children Depression Inventory with the included 27 items, each one with 3 options, from 0 (absence of symptoms) to 2 (severe symptoms).
The total score ranges from 0-54.
Higher scores mean higher depression.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Changes in Adolescent character
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by the Temperament and Character Inventory-Revised.
It consists of 240 items and 5 options for each one.
It measures 4 temperaments, Novelty Seeking (NS), Harm Avoidance (HA), Reward Dependence (RD), and Persistence (PS), and three characters, Self-directedness (SD), Cooperativeness (CO), and Self-transcendence (ST).
Each item is scored from 1 to 5 with higher scores meaning higher levels in each dimension.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Changes in Behavior
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by the Child Behavior Checklist inside the Achenbach System of Empirically Based Assessment to assess adolescents' psychopathology.
It consists of 113 items and the parents must complete it to evaluate emotional and behavioural problems in children and adolescents.
It is scored from 0="not true" to 2="true".
Raw scores range from 0 to 226.
Higher scores mean a worse outcome.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Changes in Strength
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Measured by a handgrip dynamometer (Takei) to evaluate the maximum strength applied with the hand.
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Changes in Body mass
Time Frame: At baseline and inmediately after the intervention (within 7 days after the last session)
|
Assessed using a weighing device
|
At baseline and inmediately after the intervention (within 7 days after the last session)
|
Treatment satisfaction
Time Frame: Inmediately after the intervention (within 7 days after the last session)
|
Measured by the treatment satisfaction scale (CRES-4) by Feixas i Viaplana et al., 2012, which consists of 3 dimensions.
The score in each one ranges from 0 to 100 and the global score is the sum of the dimensions (from 0 to 300).
Higher scores mean higher satisfaction.
|
Inmediately after the intervention (within 7 days after the last session)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Daniel Collado-Mateo, PhD, Universidad Rey Juan Carlos
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAT_Eat_Disorders
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eating Disorders
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council... and other collaboratorsActive, not recruitingEating Disorders | Eating Behavior | Orthodontic Appliance Complication | Eating HabitTurkey
-
Shalvata Mental Health CenterUniversity of Haifa; The Touro College and University SystemUnknownBinge-Eating Disorder | Bulimia Nervosa | Night-eating Syndrome
-
Stanford UniversityNational Institute of Mental Health (NIMH)RecruitingEating DisorderUnited States
-
Cornell CollegeNational Institute of Mental Health (NIMH)Completed
-
McMaster UniversityCompletedEating DisorderCanada
-
Washington University School of MedicineCompletedEating Disorder
-
Laval UniversityCanadian Foundation for Dietetic Research (CFDR)Completed
-
Lindner Center of HOPEUniversity of CincinnatiCompleted
-
Icahn School of Medicine at Mount SinaiRecruitingEating DisorderUnited States
-
Oregon Research InstituteStanford University; University of Texas at Austin; Trinity University, TexasCompletedEating DisorderUnited States
Clinical Trials on Dog-Assisted Therapy
-
Daniel Collado-MateoAsociación Dame La PataRecruitingWork Related Stress | Occupational GroupsSpain
-
Daniel Collado-MateoAsociación de Padres de Personas Con Autismo (APNA); Asociación Nuevo Horizonte and other collaboratorsEnrolling by invitationAutism Spectrum Disorder | AutismSpain
-
Kaiser PermanenteSeattle Children's HospitalActive, not recruitingPediatric Cancer, Animal-Assisted ActivitiesUnited States
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Texas Tech UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...UnknownAutism Spectrum Disorder | Social SkillsUnited States
-
University of BaselRecruitingMotivation | Alliance, TherapeuticSwitzerland
-
Dr. Karin HedigerCompletedAnimal-assisted InterventionSwitzerland
-
The University of Texas Health Science Center,...The Methodist Hospital Research InstituteCompletedPsychosocial StressUnited States
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
-
Indiana UniversityHealthcare Initiatives, Inc.WithdrawnChronic Pain | Anxiety AcuteUnited States